A new survey of clinicians from 21 different countries has found a lack of consensus regarding the definition of familial amyotrophic lateral sclerosis. In addition, attitudes towards genetic testing vary greatly between practitioners. These attitudes must be changed if future therapeutic strategies are to succeed.
Refers to Vajda, A. et al. Genetic testing in ALS: a survey of current practices. Neurology88, 991–999 (2017).